The Ensign Group, Inc. (NASDAQ: ENSG) Stock Competitors & Peer Comparison
See ENSG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ENSG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENSG | $179.92 | -1.41% | 10.6B | 26.45 | $6.90 | +0.14% |
| HCA | $405.34 | -1.55% | 88.1B | 14.05 | $28.96 | +0.73% |
| THC | $274.05 | +1.42% | 21.6B | 15.58 | $17.24 | N/A |
| FMS | $23.57 | +0.02% | 12.8B | 8.97 | $2.66 | +3.62% |
| EHC | $121.52 | -0.48% | 12.1B | 20.85 | $5.84 | +0.63% |
| BTSGU | $196.58 | +0.04% | 11.5B | 176.91 | $1.11 | N/A |
| DVA | $175.75 | -1.21% | 11.4B | 13.85 | $12.80 | N/A |
| UHS | $173.71 | +0.36% | 10.4B | 7.65 | $22.54 | +0.46% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $537.72 | +1.60% | 7B | 24.84 | $21.61 | +0.47% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
ENSG vs HCA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, HCA has a market cap of 88.1B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while HCA trades at $405.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas HCA's P/E ratio is 14.05. In terms of profitability, ENSG's ROE is +0.17%, compared to HCA's ROE of -1.13%. Regarding short-term risk, ENSG is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
ENSG vs THC Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while THC trades at $274.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas THC's P/E ratio is 15.58. In terms of profitability, ENSG's ROE is +0.17%, compared to THC's ROE of +0.51%. Regarding short-term risk, ENSG is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
ENSG vs FMS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while FMS trades at $23.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas FMS's P/E ratio is 8.97. In terms of profitability, ENSG's ROE is +0.17%, compared to FMS's ROE of +0.07%. Regarding short-term risk, ENSG is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
ENSG vs EHC Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while EHC trades at $121.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas EHC's P/E ratio is 20.85. In terms of profitability, ENSG's ROE is +0.17%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ENSG is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
ENSG vs BTSGU Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while BTSGU trades at $196.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas BTSGU's P/E ratio is 176.91. In terms of profitability, ENSG's ROE is +0.17%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, ENSG is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
ENSG vs DVA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, DVA has a market cap of 11.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while DVA trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas DVA's P/E ratio is 13.85. In terms of profitability, ENSG's ROE is +0.17%, compared to DVA's ROE of -1.24%. Regarding short-term risk, ENSG is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
ENSG vs UHS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, UHS has a market cap of 10.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while UHS trades at $173.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas UHS's P/E ratio is 7.65. In terms of profitability, ENSG's ROE is +0.17%, compared to UHS's ROE of +0.21%. Regarding short-term risk, ENSG is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
ENSG vs OSH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas OSH's P/E ratio is -17.65. In terms of profitability, ENSG's ROE is +0.17%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ENSG is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
ENSG vs CHE Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CHE trades at $537.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CHE's P/E ratio is 24.84. In terms of profitability, ENSG's ROE is +0.17%, compared to CHE's ROE of +0.29%. Regarding short-term risk, ENSG is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
ENSG vs PACS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, PACS has a market cap of 6.9B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while PACS trades at $44.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas PACS's P/E ratio is 23.17. In terms of profitability, ENSG's ROE is +0.17%, compared to PACS's ROE of +0.27%. Regarding short-term risk, ENSG is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check PACS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
ENSG vs LHCG Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ENSG's ROE is +0.17%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
ENSG vs LFST Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, LFST has a market cap of 5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while LFST trades at $12.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas LFST's P/E ratio is 96.63. In terms of profitability, ENSG's ROE is +0.17%, compared to LFST's ROE of +0.03%. Regarding short-term risk, ENSG is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
ENSG vs CON Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CON trades at $34.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CON's P/E ratio is 24.13. In terms of profitability, ENSG's ROE is +0.17%, compared to CON's ROE of +0.47%. Regarding short-term risk, ENSG is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
ENSG vs NHC Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NHC has a market cap of 3.7B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NHC trades at $237.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NHC's P/E ratio is 29.77. In terms of profitability, ENSG's ROE is +0.17%, compared to NHC's ROE of +0.13%. Regarding short-term risk, ENSG is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
ENSG vs OPCH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while OPCH trades at $23.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas OPCH's P/E ratio is 13.58. In terms of profitability, ENSG's ROE is +0.17%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, ENSG is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
ENSG vs AMED Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AMED's P/E ratio is 39.30. In terms of profitability, ENSG's ROE is +0.17%, compared to AMED's ROE of +0.11%. Regarding short-term risk, ENSG is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
ENSG vs BKD Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while BKD trades at $12.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas BKD's P/E ratio is -20.87. In terms of profitability, ENSG's ROE is +0.17%, compared to BKD's ROE of +4.06%. Regarding short-term risk, ENSG is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check BKD's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
ENSG vs AVAH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AVAH has a market cap of 2.9B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AVAH trades at $13.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AVAH's P/E ratio is 19.35. In terms of profitability, ENSG's ROE is +0.17%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, ENSG is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AVAH's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
ENSG vs ACHC Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ACHC trades at $27.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ACHC's P/E ratio is 13.75. In terms of profitability, ENSG's ROE is +0.17%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, ENSG is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
ENSG vs GRDN Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while GRDN trades at $37.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas GRDN's P/E ratio is 33.32. In terms of profitability, ENSG's ROE is +0.17%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, ENSG is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check GRDN's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
ENSG vs ADUS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ADUS trades at $120.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ADUS's P/E ratio is 17.97. In terms of profitability, ENSG's ROE is +0.17%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
ENSG vs MD Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while MD trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas MD's P/E ratio is 11.71. In terms of profitability, ENSG's ROE is +0.17%, compared to MD's ROE of +0.20%. Regarding short-term risk, ENSG is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
ENSG vs SEM Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SEM's P/E ratio is 15.43. In terms of profitability, ENSG's ROE is +0.17%, compared to SEM's ROE of +0.08%. Regarding short-term risk, ENSG is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
ENSG vs ASTH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ASTH trades at $39.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ASTH's P/E ratio is 37.88. In terms of profitability, ENSG's ROE is +0.17%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, ENSG is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
ENSG vs SNDA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SNDA trades at $40.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SNDA's P/E ratio is -7.54. In terms of profitability, ENSG's ROE is +0.17%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, ENSG is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
ENSG vs AMEH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ENSG's ROE is +0.17%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, ENSG is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AMEH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
ENSG vs SGRY Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SGRY trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SGRY's P/E ratio is 34.87. In terms of profitability, ENSG's ROE is +0.17%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, ENSG is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SGRY's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
ENSG vs HCSG Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while HCSG trades at $22.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas HCSG's P/E ratio is 18.34. In terms of profitability, ENSG's ROE is +0.17%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, ENSG is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
ENSG vs AGL Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AGL trades at $95.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AGL's P/E ratio is -10.48. In terms of profitability, ENSG's ROE is +0.17%, compared to AGL's ROE of -1.19%. Regarding short-term risk, ENSG is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
ENSG vs ARDT Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ARDT trades at $10.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ARDT's P/E ratio is 8.59. In terms of profitability, ENSG's ROE is +0.17%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, ENSG is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
ENSG vs INNV Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while INNV trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas INNV's P/E ratio is -121.56. In terms of profitability, ENSG's ROE is +0.17%, compared to INNV's ROE of -0.09%. Regarding short-term risk, ENSG is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check INNV's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
ENSG vs AMN Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AMN has a market cap of 1.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AMN trades at $34.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AMN's P/E ratio is 11.74. In terms of profitability, ENSG's ROE is +0.17%, compared to AMN's ROE of +0.15%. Regarding short-term risk, ENSG is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AMN's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
ENSG vs PNTG Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while PNTG trades at $38.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas PNTG's P/E ratio is 29.65. In terms of profitability, ENSG's ROE is +0.17%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
ENSG vs NUTX Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NUTX trades at $188.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NUTX's P/E ratio is 14.50. In terms of profitability, ENSG's ROE is +0.17%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, ENSG is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
ENSG vs BKDT Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas BKDT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, ENSG is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
ENSG vs USPH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while USPH trades at $79.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas USPH's P/E ratio is 31.15. In terms of profitability, ENSG's ROE is +0.17%, compared to USPH's ROE of -0.01%. Regarding short-term risk, ENSG is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
ENSG vs TALK Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TALK's P/E ratio is 774.34. In terms of profitability, ENSG's ROE is +0.17%, compared to TALK's ROE of +0.00%. Regarding short-term risk, ENSG is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
ENSG vs FSHCX Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, FSHCX has a market cap of 873.3M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while FSHCX trades at $114.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas FSHCX's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to FSHCX's ROE of N/A. Regarding short-term risk, ENSG is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
ENSG vs GMRS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, GMRS has a market cap of 777.8M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while GMRS trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas GMRS's P/E ratio is 6.40. In terms of profitability, ENSG's ROE is +0.17%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, ENSG is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
ENSG vs EHAB Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas EHAB's P/E ratio is -197.14. In terms of profitability, ENSG's ROE is +0.17%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, ENSG is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
ENSG vs STLN Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, STLN has a market cap of 665.9M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while STLN trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas STLN's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to STLN's ROE of +2.10%. Regarding short-term risk, ENSG is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
ENSG vs TOI Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TOI's P/E ratio is -14.25. In terms of profitability, ENSG's ROE is +0.17%, compared to TOI's ROE of +2.10%. Regarding short-term risk, ENSG is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
ENSG vs SRTA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SRTA has a market cap of 509.6M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SRTA trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SRTA's P/E ratio is -27.76. In terms of profitability, ENSG's ROE is +0.17%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, ENSG is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
ENSG vs MCTA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas MCTA's P/E ratio is 419.36. In terms of profitability, ENSG's ROE is +0.17%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, ENSG is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
ENSG vs CYH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CYH has a market cap of 413.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CYH trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CYH's P/E ratio is 4.01. In terms of profitability, ENSG's ROE is +0.17%, compared to CYH's ROE of +0.21%. Regarding short-term risk, ENSG is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
ENSG vs AUNA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AUNA has a market cap of 404.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AUNA trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AUNA's P/E ratio is 4.92. In terms of profitability, ENSG's ROE is +0.17%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, ENSG is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
ENSG vs VMD Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, VMD has a market cap of 340.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while VMD trades at $8.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas VMD's P/E ratio is 24.83. In terms of profitability, ENSG's ROE is +0.17%, compared to VMD's ROE of +0.10%. Regarding short-term risk, ENSG is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
ENSG vs CSU Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CSU's P/E ratio is 0.67. In terms of profitability, ENSG's ROE is +0.17%, compared to CSU's ROE of -0.33%. Regarding short-term risk, ENSG is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
ENSG vs AIRS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AIRS has a market cap of 198.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AIRS trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AIRS's P/E ratio is -93.67. In terms of profitability, ENSG's ROE is +0.17%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, ENSG is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
ENSG vs JYNT Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, JYNT has a market cap of 117.6M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while JYNT trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas JYNT's P/E ratio is 82.50. In terms of profitability, ENSG's ROE is +0.17%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, ENSG is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
ENSG vs PARK Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, PARK has a market cap of 99.1M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while PARK trades at $21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas PARK's P/E ratio is 29.65. In terms of profitability, ENSG's ROE is +0.17%, compared to PARK's ROE of -0.18%. Regarding short-term risk, ENSG is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
ENSG vs FVE Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas FVE's P/E ratio is -5.64. In terms of profitability, ENSG's ROE is +0.17%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
ENSG vs KDLYW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, ENSG is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
ENSG vs BTMD Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, BTMD has a market cap of 61.3M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while BTMD trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas BTMD's P/E ratio is 12.64. In terms of profitability, ENSG's ROE is +0.17%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, ENSG is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
ENSG vs ALR Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ALR's P/E ratio is -1.11. In terms of profitability, ENSG's ROE is +0.17%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
ENSG vs DCGO Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, DCGO has a market cap of 41.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while DCGO trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas DCGO's P/E ratio is -0.22. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, ENSG is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check DCGO's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
ENSG vs PIII Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, PIII has a market cap of 33.6M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while PIII trades at $10.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas PIII's P/E ratio is -0.26. In terms of profitability, ENSG's ROE is +0.17%, compared to PIII's ROE of +1.61%. Regarding short-term risk, ENSG is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
ENSG vs CCEL Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CCEL has a market cap of 33.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CCEL trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CCEL's P/E ratio is -13.73. In terms of profitability, ENSG's ROE is +0.17%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, ENSG is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
ENSG vs IMAC Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ENSG's ROE is +0.17%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, ENSG is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check IMAC's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ENSG vs EUDA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while EUDA trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas EUDA's P/E ratio is -26.64. In terms of profitability, ENSG's ROE is +0.17%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, ENSG is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
ENSG vs CANO-WT Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, ENSG is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
ENSG vs AIH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AIH's P/E ratio is -2.78. In terms of profitability, ENSG's ROE is +0.17%, compared to AIH's ROE of +1.16%. Regarding short-term risk, ENSG is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
ENSG vs CANO Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CANO's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO's ROE of -1.49%. Regarding short-term risk, ENSG is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
ENSG vs FPCG Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas FPCG's P/E ratio is 0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, ENSG is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
ENSG vs AMS Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AMS trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AMS's P/E ratio is -6.69. In terms of profitability, ENSG's ROE is +0.17%, compared to AMS's ROE of -0.07%. Regarding short-term risk, ENSG is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
ENSG vs FTRP Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ENSG's ROE is +0.17%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ENSG is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
ENSG vs BMGL Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, BMGL has a market cap of 7.7M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while BMGL trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas BMGL's P/E ratio is -0.93. In terms of profitability, ENSG's ROE is +0.17%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, ENSG is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
ENSG vs XWEL Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, XWEL has a market cap of 7.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while XWEL trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas XWEL's P/E ratio is -0.18. In terms of profitability, ENSG's ROE is +0.17%, compared to XWEL's ROE of +3.18%. Regarding short-term risk, ENSG is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
ENSG vs AIDX Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AIDX has a market cap of 6.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AIDX trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AIDX's P/E ratio is -0.96. In terms of profitability, ENSG's ROE is +0.17%, compared to AIDX's ROE of +2.14%. Regarding short-term risk, ENSG is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
ENSG vs MODV Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas MODV's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to MODV's ROE of +1.36%. Regarding short-term risk, ENSG is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check MODV's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
ENSG vs STLNW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, STLNW has a market cap of 5.8M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas STLNW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to STLNW's ROE of N/A. Regarding short-term risk, ENSG is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check STLNW's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
ENSG vs GBNH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, ENSG is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
ENSG vs RHE-PA Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, ENSG is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
ENSG vs RHE Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas RHE's P/E ratio is -1.79. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE's ROE of -1.31%. Regarding short-term risk, ENSG is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
ENSG vs TOIIW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, ENSG's ROE is +0.17%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, ENSG is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
ENSG vs IMACW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas IMACW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, ENSG is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
ENSG vs NAKAW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, ENSG's ROE is +0.17%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, ENSG is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
ENSG vs CCM Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, CCM has a market cap of 706.2K. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while CCM trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas CCM's P/E ratio is -0.32. In terms of profitability, ENSG's ROE is +0.17%, compared to CCM's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
ENSG vs NIVF Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NIVF has a market cap of 104.1K. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NIVF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NIVF's P/E ratio is 0.27. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, ENSG is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
ENSG vs MNDR Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, MNDR has a market cap of 40.8K. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas MNDR's P/E ratio is -0.04. In terms of profitability, ENSG's ROE is +0.17%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, ENSG is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
ENSG vs NIVFW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, ENSG is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
ENSG vs TALKW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TALKW's P/E ratio is 0.00. In terms of profitability, ENSG's ROE is +0.17%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, ENSG is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TALKW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
ENSG vs KND Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, KND has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas KND's P/E ratio is -1.14. In terms of profitability, ENSG's ROE is +0.17%, compared to KND's ROE of -0.53%. Regarding short-term risk, ENSG is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check KND's competition here
New Frontier Health Corporation (NYSE: NFH)
ENSG vs NFH Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, NFH has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas NFH's P/E ratio is -19.75. In terms of profitability, ENSG's ROE is +0.17%, compared to NFH's ROE of -0.06%. Regarding short-term risk, ENSG is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NFH's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
ENSG vs ATIP-WT Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, ENSG is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ATIP-WT's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
ENSG vs DVCR Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas DVCR's P/E ratio is 28.34. In terms of profitability, ENSG's ROE is +0.17%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check DVCR's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
ENSG vs SLHG Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SLHG's P/E ratio is -1.48. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHG's ROE of N/A. Regarding short-term risk, ENSG is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check SLHG's competition here
Hanger, Inc. (NYSE: HNGR)
ENSG vs HNGR Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas HNGR's P/E ratio is 19.71. In terms of profitability, ENSG's ROE is +0.17%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, ENSG is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check HNGR's competition here
Almost Family Inc. (NASDAQ: AFAM)
ENSG vs AFAM Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas AFAM's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, ENSG is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AFAM's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
ENSG vs SLHGP Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, ENSG is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SLHGP's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
ENSG vs TLMD Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TLMD's P/E ratio is -1.60. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, ENSG is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TLMD's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
ENSG vs TLMDW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TLMDW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, ENSG is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TLMDW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
ENSG vs TVTY Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas TVTY's P/E ratio is 19.06. In terms of profitability, ENSG's ROE is +0.17%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, ENSG is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
ENSG vs DCGOW Comparison August 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10.6B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, ENSG is priced at $179.92 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 26.45, whereas DCGOW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, ENSG is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check DCGOW's competition here